BTL-785-7 Treatment for Wrinkles

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Refresh Dermatology, Houston, TX
Wrinkles
BTL-785-7 Treatment - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study will evaluate the clinical safety and the efficacy of the BTL-785F system equipped with the BTL-785-7 applicator for non-invasive facial treatment in patients injected with botulinum toxin. The aim is to investigate the improvement of overall facial appearance and muscle tone.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 3 Secondary · Reporting Duration: 5 months

5 months
Facial Appearance Change
Facial Appearance Improvement
Facial expression assessment
Subject Satisfaction
Therapy Comfort

Trial Safety

Trial Design

2 Treatment Groups

Control
1 of 2
BTL-785-7 Treatment
1 of 2
Active Control
Experimental Treatment

13 Total Participants · 2 Treatment Groups

Primary Treatment: BTL-785-7 Treatment · No Placebo Group · N/A

BTL-785-7 Treatment
Device
Experimental Group · 1 Intervention: BTL-785-7 Treatment · Intervention Types: Device
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 5 months
Closest Location: Refresh Dermatology · Houston, TX
Photo of Houston 1Photo of Houston 2Photo of Houston 3
2019First Recorded Clinical Trial
1 TrialsResearching Wrinkles
3 CompletedClinical Trials

Who is running the clinical trial?

BTL Industries Ltd.Lead Sponsor
42 Previous Clinical Trials
1,497 Total Patients Enrolled
9 Trials studying Wrinkles
270 Patients Enrolled for Wrinkles

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
Subjects injected with type A botulinum toxin for facial wrinkles improvement in the past month, but no sooner than 1 week.
You are willing and able to abstain from any facial treatments other than the study procedure during study participation.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.